Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 30-Nov-16 7:53 PM View:  | Harshbarger Benjamin General Counsel and Secretary | Aegerion Pharmaceuticals, I... (AEGR) | 29-Nov-16 | Disposition | 1,704 | -- | -- | (100%) 1.7K to 0 | |
| 30-Nov-16 7:50 PM View: | Thomas Paul Director | Aegerion Pharmaceuticals, I... (AEGR) | 29-Nov-16 | Disposition | 36,978 | -- | -- | (100%) 36.98K to 0 | |
| 30-Nov-16 7:48 PM View: | Scheer David Director | Aegerion Pharmaceuticals, I... (AEGR) | 29-Nov-16 | Disposition | 10,000 | -- | -- | (2%) 531.35K to 521.35K | |
| 30-Nov-16 7:47 PM View: | Barer Sol J Director | Aegerion Pharmaceuticals, I... (AEGR) | 29-Nov-16 | Disposition | 29,890 | -- | -- | (100%) 29.89K to 0 | |
| 30-Nov-16 7:48 PM View: | Gotto Antonio M Jr Md D Phil Director | Aegerion Pharmaceuticals, I... (AEGR) | 29-Nov-16 | Disposition | 13,916 | -- | -- | (100%) 13.92K to 0 | |
| 01-Dec-16 5:44 PM View: | Broadfin Healthcare Master ... 10% Owner | Aegerion Pharmaceuticals, I... (AEGR) | 29-Nov-16 | Disposition | 4,361,290 | -- | -- | (100%) 4.36M to 0 | |
| 30-Nov-16 7:48 PM View: | Scheer David Director | Aegerion Pharmaceuticals, I... (AEGR) | 29-Nov-16 | Disposition | 521,350 | -- | -- | (100%) 521.35K to 0 | |
| 30-Nov-16 7:51 PM View: | Vanlent Anne Director | Aegerion Pharmaceuticals, I... (AEGR) | 29-Nov-16 | Disposition | 4,000 | -- | -- | (100%) 4.0K to 0 | |
| 30-Nov-16 7:49 PM View: | Smith Sandford D Director | Aegerion Pharmaceuticals, I... (AEGR) | 29-Nov-16 | Disposition | 2,890 | -- | -- | (100%) 2.89K to 0 | |
| 20-Sep-16 4:03 PM View: | Harshbarger Benjamin Acting General Counsel | Aegerion Pharmaceuticals, I... (AEGR) | 17-Sep-16 | Payment of Exercise | 532 | $1.78 | $946.96 | (24%) 2.24K to 1.7K | (8%) |
| 20-Sep-16 4:03 PM View: | Harshbarger Benjamin Acting General Counsel | Aegerion Pharmaceuticals, I... (AEGR) | 17-Sep-16 | Option Exercise | 1,642 | -- | -- | 276% 0.59K to 2.24K | |
| 14-Sep-16 4:16 PM View: | Broadfin Healthcare Master ... 10% Owner | Aegerion Pharmaceuticals, I... (AEGR) | 13-Sep-16 | Market Purchase | 75,000 | $1.75 | $131,250.00 | 2% 4.29M to 4.36M | 10% |
| 12-Sep-16 6:44 PM View: | Broadfin Healthcare Master ... 10% Owner | Aegerion Pharmaceuticals, I... (AEGR) | 12-Sep-16 | Market Purchase | 176,000 | $1.70 | $298,800.00 | 4% 4.11M to 4.29M | 13% |
| 12-Sep-16 6:44 PM View: | Broadfin Healthcare Master ... 10% Owner | Aegerion Pharmaceuticals, I... (AEGR) | 09-Sep-16 | Market Purchase | 100,000 | $1.60 | $159,500.00 | 2% 4.01M to 4.11M | 20% |
| 29-Jul-16 4:01 PM View: | Smith Sandford D Director | Aegerion Pharmaceuticals, I... (AEGR) | 27-Jul-16 | Option Exercise | 2,222 | -- | -- | 154% 1.45K to 3.67K | |
| 29-Jul-16 4:01 PM View: | Smith Sandford D Director | Aegerion Pharmaceuticals, I... (AEGR) | 27-Jul-16 | Payment of Exercise | 777 | $1.55 | $1,204.35 | (21%) 3.67K to 2.89K | (24%) |
| 20-Sep-16 4:03 PM View: | Harshbarger Benjamin General Counsel | Aegerion Pharmaceuticals, I... (AEGR) | 01-Apr-16 | Option Exercise | 867 | -- | -- | 100% 0 to 0.87K | |
| 20-Sep-16 4:03 PM View: | Harshbarger Benjamin General Counsel | Aegerion Pharmaceuticals, I... (AEGR) | 01-Apr-16 | Payment of Exercise | 273 | $3.55 | $969.15 | (31%) 0.87K to 0.59K | 46% |
| 21-Mar-16 4:48 PM View: | Broadfin Healthcare Master ... 10% Owner | Aegerion Pharmaceuticals, I... (AEGR) | 18-Mar-16 | Exercise (in-the money or at-the-money) | 497,600 | $7.50 | $3,732,000.00 | 14% 3.51M to 4.01M | |
| 21-Mar-16 4:48 PM View: | Broadfin Healthcare Master ... 10% Owner | Aegerion Pharmaceuticals, I... (AEGR) | 17-Mar-16 | Exercise (in-the money or at-the-money) | 2,400 | $7.50 | $18,000.00 | < 1% 3.51M to 3.51M | |
| 29-Jan-16 6:05 AM View: | Smith Sandford D Director | Aegerion Pharmaceuticals, I... (AEGR) | 27-Jan-16 | Option Exercise | 2,223 | -- | -- | 100% 0 to 2.22K | |
| 29-Jan-16 6:05 AM View: | Smith Sandford D Director | Aegerion Pharmaceuticals, I... (AEGR) | 27-Jan-16 | Payment of Exercise | 778 | $6.78 | $5,274.84 | (35%) 2.22K to 1.45K | 72% |
| 03-Dec-15 4:01 PM View: | Scheer David Director | Aegerion Pharmaceuticals, I... (AEGR) | 01-Dec-15 | Disposition (other) | 65,869 | -- | -- | (6%) 1.18M to 1.12M | |
| 13-Nov-15 3:24 PM View: | Broadfin Healthcare Master ... 10% Owner | Aegerion Pharmaceuticals, I... (AEGR) | 11-Nov-15 | Market Purchase | 40,100 | $10.96 | $439,649.00 | 1% 3.97M to 4.01M | (82%) |
| 02-Sep-14 5:10 PM View: | Beer Marc D Chief Executive Officer Director | Aegerion Pharmaceuticals, I... (AEGR) | 28-Aug-14 | Gift | 769 | -- | -- | (< 1%) 325.86K to 325.09K | |
| 20-Aug-14 9:36 AM View: | Fitzpatrick Mark J. Chief Financial Officer | Aegerion Pharmaceuticals, I... (AEGR) | 19-Aug-14 | Market Purchase | 1,150 | $30.64 | $35,236.00 | 14% 8.35K to 9.5K | (94%) |
| 31-Jul-14 12:30 PM View: | Beer Marc D Chief Executive Officer Director | Aegerion Pharmaceuticals, I... (AEGR) | 31-Jul-14 | Market Purchase | 10,000 | $33.65 | $336,539.00 | 3% 315.86K to 325.86K | (94%) |
| 04-Jun-14 9:30 AM View: | Beer Marc D Chief Executive Officer Director | Aegerion Pharmaceuticals, I... (AEGR) | 03-Jun-14 | Market Purchase | 10,000 | $30.12 | $301,200.00 | 3% 305.86K to 315.86K | (94%) |
| 27-May-14 12:57 PM View: | Beer Marc D Chief Executive Officer Director | Aegerion Pharmaceuticals, I... (AEGR) | 27-May-14 | Market Purchase | 10,000 | $31.59 | $315,900.00 | 3% 295.86K to 305.86K | (94%) |
| 22-May-14 9:39 AM View: | Beer Marc D Chief Executive Officer Director | Aegerion Pharmaceuticals, I... (AEGR) | 21-May-14 | Option Exercise | 6,400 | $1.54 | $9,856.00 | 2% 289.46K to 295.86K | |
| 21-May-14 9:40 AM View: | Beer Marc D Chief Executive Officer Director | Aegerion Pharmaceuticals, I... (AEGR) | 20-May-14 | Market Purchase | 10,000 | $30.53 | $305,300.00 | 4% 279.46K to 289.46K | (94%) |
| 08-May-14 10:20 AM View: | Beer Marc D Chief Executive Officer Director | Aegerion Pharmaceuticals, I... (AEGR) | 08-May-14 | Market Purchase | 30,000 | $35.31 | $1,059,300.00 | 12% 249.46K to 279.46K | (95%) |
| 09-May-14 9:24 AM View: | Vanlent Anne Director | Aegerion Pharmaceuticals, I... (AEGR) | 08-May-14 | Market Purchase | 4,000 | $33.78 | $135,110.00 | 100% 0 to 4.0K | (94%) |
| 01-May-14 4:01 PM View: | Fraser Craig Pres., US/Int. Comm. & Manuf. | Aegerion Pharmaceuticals, I... (AEGR) | 30-Apr-14 | Option Exercise | 2,250 | $13.01 | $29,272.50 | 100% 0 to 2.25K | |
| 01-May-14 4:01 PM View: | Fraser Craig Pres., US/Int. Comm. & Manuf. | Aegerion Pharmaceuticals, I... (AEGR) | 30-Apr-14 | Market Option Sale (Planned) | 2,250 | $43.55 | $97,998.10 | (100%) 2.25K to 0 | 96% |
| 02-Apr-14 4:01 PM View: | Fraser Craig Pres., US/Int. Comm. & Manuf. | Aegerion Pharmaceuticals, I... (AEGR) | 31-Mar-14 | Market Option Sale (Planned) | 2,250 | $46.20 | $103,947.00 | (100%) 2.25K to 0 | 96% |
| 02-Apr-14 4:01 PM View: | Fraser Craig Pres., US/Int. Comm. & Manuf. | Aegerion Pharmaceuticals, I... (AEGR) | 31-Mar-14 | Option Exercise | 2,250 | $13.01 | $29,272.50 | 100% 0 to 2.25K | |
| 27-Mar-14 5:26 PM View: | Beer Marc D Chief Executive Officer Director | Aegerion Pharmaceuticals, I... (AEGR) | 26-Mar-14 | Option Exercise | 3,000 | $1.54 | $4,620.00 | 1% 246.46K to 249.46K | |
| 18-Mar-14 4:01 PM View: | Sumeray Mark Chief Medical Officer | Aegerion Pharmaceuticals, I... (AEGR) | 14-Mar-14 | Market Option Sale (Planned) | 2,000 | $51.33 | $102,670.00 | (100%) 2.0K to 0 | 96% |
| 18-Mar-14 4:01 PM View: | Sumeray Mark Chief Medical Officer | Aegerion Pharmaceuticals, I... (AEGR) | 14-Mar-14 | Option Exercise | 2,000 | $13.01 | $26,020.00 | 100% 0 to 2.0K | |
| 05-Mar-14 6:46 PM View: | Fitzpatrick Mark J. Chief Financial Officer | Aegerion Pharmaceuticals, I... (AEGR) | 04-Mar-14 | Option Exercise | 2,500 | $17.64 | $44,100.00 | 43% 5.85K to 8.35K | |
| 18-Feb-14 4:05 PM View: | Sumeray Mark Chief Medical Officer | Aegerion Pharmaceuticals, I... (AEGR) | 14-Feb-14 | Option Exercise | 2,000 | $13.01 | $26,020.00 | 100% 0 to 2.0K | |
| 18-Feb-14 4:05 PM View: | Sumeray Mark Chief Medical Officer | Aegerion Pharmaceuticals, I... (AEGR) | 14-Feb-14 | Market Option Sale (Planned) | 2,000 | $63.49 | $126,970.00 | (100%) 2.0K to 0 | 97% |
| 12-Feb-14 4:01 PM View: | Fraser Craig Pres., US/Int. Comm. & Manuf. | Aegerion Pharmaceuticals, I... (AEGR) | 11-Feb-14 | Market Option Sale (Planned) | 2,250 | $67.00 | $150,750.00 | (100%) 2.25K to 0 | 97% |
| 12-Feb-14 4:01 PM View: | Fraser Craig Pres., US/Int. Comm. & Manuf. | Aegerion Pharmaceuticals, I... (AEGR) | 11-Feb-14 | Option Exercise | 2,250 | $13.01 | $29,272.50 | 100% 0 to 2.25K | |
| 12-Feb-14 4:01 PM View: | Fitzpatrick Mark J. Chief Financial Officer | Aegerion Pharmaceuticals, I... (AEGR) | 10-Feb-14 | Option Exercise | 7,500 | $17.64 | $132,300.00 | 128% 5.85K to 13.35K | |
| 12-Feb-14 4:01 PM View: | Fitzpatrick Mark J. Chief Financial Officer | Aegerion Pharmaceuticals, I... (AEGR) | 10-Feb-14 | Market Option Sale (Planned) | 7,500 | $62.61 | $469,543.00 | (56%) 13.35K to 5.85K | 97% |
| 21-Jan-14 4:01 PM View: | Sumeray Mark Chief Medical Officer | Aegerion Pharmaceuticals, I... (AEGR) | 16-Jan-14 | Market Option Sale (Planned) | 2,000 | $58.63 | $117,269.00 | (100%) 2.0K to 0 | 97% |
| 21-Jan-14 4:01 PM View: | Sumeray Mark Chief Medical Officer | Aegerion Pharmaceuticals, I... (AEGR) | 16-Jan-14 | Option Exercise | 2,000 | $13.01 | $26,020.00 | 100% 0 to 2.0K | |
| 06-Jan-14 4:01 PM View: | Sumeray Mark Chief Medical Officer | Aegerion Pharmaceuticals, I... (AEGR) | 02-Jan-14 | Market Option Sale (Planned) | 1,000 | $70.93 | $70,934.00 | (100%) 1.0K to 0 | 97% |
